๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Yancheng
Clinical trial register · China

Clinical Trials in Yancheng, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Yancheng

18 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Effectiveness of the MindBridge Mobile Health Module for Young Adults at Risk of Suicide
NCT07767604Suicidal Ideation
Jiangsu Medical College
Not applicable
84
Yancheng
2027-03
Recruiting
Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China
NCT07492498Atrial Fibrillation, Heart Failure
Jiangsu Taizhou People's Hospital
Not applicable
1,356
Yancheng, Yangzhou, Xuzhou
2026-08-01
Recruiting
Novel Model of Integrated Care of Older Patients With Atrial Fibrillation and Heart Failure in Rural China (MIRACLE-AFHF)
NCT07492524Atrial Fibrillation, Heart Failure
Jiangsu Taizhou People's Hospital
Not applicable
942
Yancheng, Yangzhou, Xuzhou
2026-08-01
Not yet open
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellviยฎ
NCT07663526Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
50
Fuyang, Zhengzhou, Zhoukou, Huaian, Yancheng, Meihekou, Shanghai
2026-08
Not yet open
Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation
NCT07426068Metabolic Disease, Amyotrophy
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
Phase EARLY_PHASE1
6
Yancheng, Beijing
2026-07-01
Not yet open
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
NCT07338851Polio, Measles, Rubella, Mumps
China National Biotec Group Company Limited
Observational
600
Suzhou, Handan, Yancheng, Hanzhong, Yuncheng, Mianyang
2026-01-30
Not yet open
Comparison of Initial Treatment for Carpal Tunnel Syndrome Related to Rheumatic Diseases: Corticosteroid Injection Versus Nighttime Splinting
NCT07042282Carpal Tunnel Syndrome (CTS), Rheumatic Diseases
Yun Qian
Not applicable
248
Jinjiang, Yancheng, Shanghai
2025-08-01
Not yet open
Comparison of Corticosteroid Injection, Nighttime Splinting, or Their Combination for Initial Treatment of Moderate-to-Severe Carpal Tunnel Syndrome
NCT07043179Carpal Tunnel Syndrome (CTS)
Yun Qian
Not applicable
318
Jinjiang, Yancheng, Shanghai
2025-07-15
Recruiting
Allogeneic UCB-derived CAR-T for SLE
NCT07274059SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd.
Phase EARLY_PHASE1
48
Yancheng, Chengdu
2025-03-26
Recruiting
Effect of Aerobic Exercise With Synchronous Music on Functions Among Medical Students
NCT06788106Psychological Stress, Aerobic Exercise, Medical Students
Universiti Sains Malaysia
Not applicable
134
Yancheng
2025-02-26
Recruiting
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
NCT06607276Cholangiocarcinoma Cancer, Adebrelimab (SHR-1316)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing, Xuzhou, Yancheng
2024-09-20
Recruiting
A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
NCT06497738Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
Observational
112
Changzhou, Nanjing, Nantong, Taizhou, Yancheng
2024-05-01
Active, closed
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06243666Cervical Intraepithelial Neoplasia, Cervical Cancer, Persistent Infection
Xiamen University
Observational
2,188
Yancheng
2024-02-20
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenstrรถm Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
BeOne Medicines
Phase 2
114
Xiamen, Guangzhou, Zhengzhou, Wuhan, Yancheng, Shenyang, Qingdao, Shanghai
2023-10-23
Recruiting
Multicenter Study of Fulminant Type 1 Diabetes in China
NCT05593081Diabetes Mellitus, Type 1
Second Xiangya Hospital of Central South University
Observational
240
Quanzhou, Guangzhou, Nanning, Zunyi, Haikou, Changsha, Yancheng, Nanchang
2022-05-20
Active, closed
Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
NCT05522582Solid Tumors
Yancheng First People's Hospital
Phase 2
50
Yancheng
2021-11-15
Active, closed
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
NCT04807166Ovarian Neoplasms, Fallopian Tube Neoplasms, Neoplasms by Site, Genital Neoplasms, Female
Wenjun Cheng
Phase 2
56
Huai'an, Nanjing, Suzhou, Wuxi, Yancheng
2021-08-24
Recruiting
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma โ‰ค 2cm
NCT04937283Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/yancheng

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Yancheng.

How many clinical trials are recruiting in Yancheng?

8 of the 18 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yancheng), 18 studies
PhaseStudiesRecruitingShare
Not applicable7438.9%
Observational4222.2%
Phase 24122.2%
Phase EARLY_PHASE12111.1%
Phase 4105.6%

Most active sponsors

Lead sponsors with the most studies (Yancheng)
Lead sponsorStudiesRecruiting
Jiangsu Taizhou People's Hospital22
The First Affiliated Hospital with Nanjing Medical University22
Yun Qian20
BeOne Medicines10
Chengdu Ucello Biotechnology Co., Ltd.11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10
China National Biotec Group Company Limited10
Jiangsu Medical College10
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China10
Second Xiangya Hospital of Central South University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.